PV Bulletin
Health CanadaCanada

Omnipod Insulin Management System Recall in Canada

Health Canada posted a recall for Omnipod Insulin Management System due to product performance issues.

Primary source: Health Canada

PV Impact Brief

Urgency: HighConfidence: high

What changed

Health Canada announced a recall for Omnipod Insulin Management System due to product performance issues.

Why it matters

Product performance issues may lead to insulin delivery errors, posing serious health risks to users.

Action needed

Identify affected lots and implement recall procedures as per Health Canada guidelines.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

action required within 24 hours

Regulatory action details

Action type
Health product recall
Publication date
2026-06-01
Safety issue
Recall for Omnipod Insulin Management System due to product performance issues.

Affected products

  • Omnipod Insulin Management System
    Insulet Corporation

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 1, 2026

Full briefing

Practical implication

Identify affected lots and implement recall procedures as per Health Canada guidelines.

Recall for Omnipod Insulin Management System due to product performance issues.

What changed: Health Canada announced a recall for Omnipod Insulin Management System due to product performance issues.

Why it matters: Product performance issues may lead to insulin delivery errors, posing serious health risks to users.

Practical implication: Identify affected lots and implement recall procedures as per Health Canada guidelines.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

Related updates for your role

publicEuropean Medicines Agency · EU · Updated Jul 15, 2026

Reflection paper on particulars for safety signals for (traditional) herbal medicinal products

Urgency: High

Implement increased documentation and reporting processes for traditional herbal medicinal products. Ensure staff receive training on the complexities involved in signal management for these products.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward
publicSwissmedic · Switzerland · Updated Jul 17, 2026

Checklist for the Inspection of Medical Device Vigilance in Hospitals

Urgency: High

Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Checklist
Read impact briefarrow_forward
publicEuropean Medicines Agency · EU · Updated Jul 15, 2026

Updated eCTD v4.0 technical validation criteria

Urgency: High

All electronic PV submissions must undergo new validation checks in accordance with the updated criteria to ensure compliance and accuracy.

Country ComplianceICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Technical Guidance
Read impact briefarrow_forward
publicHealth Canada · Canada · Updated Jul 15, 2026

Order Providing for Reliance on Foreign Regulatory Authority Decisions for Certain Drugs (Ministerial Reliance Order)

Urgency: High

Manufacturers must demonstrate that any variances from the foreign authorized drugs do not adversely affect safety or effectiveness when filing for deeming under this new framework.

Country ComplianceSignal ManagementRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward